Literature DB >> 24090041

Evolution of HIV-1 coreceptor usage and coreceptor switching during pregnancy.

Doris G Ransy1, Alena Motorina, Natacha Merindol, Bertine S Akouamba, Johanne Samson, Yolanda Lie, Laura A Napolitano, Normand Lapointe, Marc Boucher, Hugo Soudeyns.   

Abstract

Coreceptor switch from CCR5 to CXCR4 is associated with HIV disease progression. To document the evolution of coreceptor tropism during pregnancy, a longitudinal study of envelope gene sequences was performed in a group of pregnant women infected with HIV-1 of clade B (n=10) or non-B (n=9). Polymerase chain reaction (PCR) amplification of the V1-V3 region was performed on plasma viral RNA, followed by cloning and sequencing. Using geno2pheno and PSSMX4R5, the presence of X4 variants was predicted in nine of 19 subjects (X4 subjects) independent of HIV-1 clade. Six of nine X4 subjects exhibited CD4(+) T cell counts <200 cells/mm(3), and the presence of X4-capable virus was confirmed using a recombinant phenotypic assay in four of seven cases where testing was successful. In five of nine X4 subjects, a statistically significant decline in the geno2pheno false-positive rate was observed during the course of pregnancy, invariably accompanied by progressive increases in the PSSMX4R5 score, the net charge of V3, and the relative representation of X4 sequences. Evolution toward X4 tropism was also echoed in the primary structure of V2, as an accumulation of substitutions associated with CXCR4 tropism was seen in X4 subjects. Results from these experiments provide the first evidence of the ongoing evolution of coreceptor utilization from CCR5 to CXCR4 during pregnancy in a significant fraction of HIV-infected women. These results inform changes in host-pathogen interactions that lead to a directional shaping of viral populations and viral tropism during pregnancy, and provide insights into the biology of HIV transmission from mother to child.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24090041      PMCID: PMC3938935          DOI: 10.1089/aid.2013.0155

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  73 in total

1.  Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C.

Authors:  Mia Coetzer; Rebecca Nedellec; Tonie Cilliers; Tammy Meyers; Lynn Morris; Donald E Mosier
Journal:  J Acquir Immune Defic Syndr       Date:  2011-01-01       Impact factor: 3.731

2.  Improved prediction of HIV‐1 coreceptor usage with sequence information from the second hypervariable loop of gp120.

Authors:  Alexander Thielen; Nadine Sichtig; Rolf Kaiser; Jeffrey Lam; P Richard Harrigan; Thomas Lengauer
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

3.  Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.

Authors:  Mattias Mild; Anders Kvist; Joakim Esbjörnsson; Ingrid Karlsson; Eva Maria Fenyö; Patrik Medstrand
Journal:  Infect Genet Evol       Date:  2009-05-14       Impact factor: 3.342

Review 4.  Gimme shelter: the immune system during pregnancy.

Authors:  Alba Munoz-Suano; Alexander B Hamilton; Alexander G Betz
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

5.  Genotypic analysis of human immunodeficiency virus type 1 env V3 loop sequences: bioinformatics prediction of coreceptor usage among 28 infected mother-infant pairs in a drug-naive population.

Authors:  Kerina Duri; White Soko; Felicity Gumbo; Knut Kristiansen; Munyaradzi Mapingure; Babill Stray-Pedersen; Fredrik Muller
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-23       Impact factor: 2.205

6.  Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection.

Authors:  David A Cooper; Jayvant Heera; James Goodrich; Margaret Tawadrous; Michael Saag; Edwin Dejesus; Nathan Clumeck; Sharon Walmsley; Naitee Ting; Eoin Coakley; Jacqueline D Reeves; Gustavo Reyes-Teran; Mike Westby; Elna Van Der Ryst; Prudence Ive; Lerato Mohapi; Horacio Mingrone; Andrzej Horban; Frances Hackman; John Sullivan; Howard Mayer
Journal:  J Infect Dis       Date:  2010-03-15       Impact factor: 5.226

7.  Effect of B-cell depletion on coreceptor switching in R5 simian-human immunodeficiency virus infection of rhesus macaques.

Authors:  Silvana Tasca; Ke Zhuang; Agegnehu Gettie; Heather Knight; James Blanchard; Susan Westmoreland; Cecilia Cheng-Mayer
Journal:  J Virol       Date:  2011-01-19       Impact factor: 5.103

8.  Molecular determinants of HIV-1 subtype C coreceptor transition from R5 to R5X4.

Authors:  Hong Zhang; Damien C Tully; Tiejun Zhang; Hideaki Moriyama; Jesse Thompson; Charles Wood
Journal:  Virology       Date:  2010-08-24       Impact factor: 3.616

9.  Co-receptor switch during HAART is independent of virological success.

Authors:  Annalisa Saracino; Laura Monno; Donatella C Cibelli; Grazia Punzi; Gaetano Brindicci; Nicoletta Ladisa; Alessandra Tartaglia; Antonella Lagioia; Gioacchino Angarano
Journal:  J Med Virol       Date:  2009-12       Impact factor: 2.327

Review 10.  HIV-1 co-receptor usage: influence on mother-to-child transmission and pediatric infection.

Authors:  Mariangela Cavarelli; Gabriella Scarlatti
Journal:  J Transl Med       Date:  2011-01-27       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.